Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain

BSE407.40-0.65 (-0.16 %)

PREV CLOSE ( ) 408.05

OPEN PRICE ( ) 414.00

BID PRICE (QTY) 406.95 (29)

OFFER PRICE (QTY) 407.90 (9)

VOLUME 4627

TODAY'S LOW / HIGH ( )406.60 414.45

52 WK LOW / HIGH ( )235.6 581

NSE408.200.75 (+0.18 %)

PREV CLOSE( ) 407.45

OPEN PRICE ( ) 414.50

BID PRICE (QTY) 407.80 (1)

OFFER PRICE (QTY) 408.30 (1)

VOLUME 37529

TODAY'S LOW / HIGH( ) 405.00 414.50

52 WK LOW / HIGH ( )235.44 581.9

Quarters

Select year

( in Million)

Particulars

Jun 2025

Mar 2025

Dec 2024

Sep 2024

Audited / UnAudited

UnAudited

Net Sales

1667

1325.3

1634.9

1473.5

Total Expenditure

1678.8

1594.1

1555.3

1403.5

PBIDT (Excl OI)

-11.8

-268.8

79.60

Other Income

56.7

85.9

36.2

46.5

Operating Profit

44.90

-182.9

115.8

116.5

Interest

8.6

10.4

9.9

9.8

Exceptional Items

113.2

277.1

27.7

PBDT

149.5

83.79

133.6

134.4

Depreciation

83.9

84.2

89.8

86.8

Profit Before Tax

65.60

-0.40

43.79

47.6

Tax

19.5

-0.6

0.5

Provisions and contingencies

Profit After Tax

39.60

-19.90

44.39

47.1

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

39.60

-19.90

44.39

47.1

Minority Interest

0.9

0.8

0.9

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

40.5

-18.9

45.2

Equity Capital

61.3

Face Value (IN RS)

Reserves

Calculated EPS

0.66

-0.30

0.73

0.78

Calculated EPS (Annualised)

2.64

-1.23

2.94

3.13

No of Public Share Holdings

16856556

16851556

16618314

% of Public Share Holdings

27.52

27.51

27.13

PBIDTM% (Excl OI)

-0.70

-20.28

4.86

4.75

PBIDTM%

2.69

-13.80

7.08

7.90

PBDTM%

8.96

6.32

8.17

9.12

PBTM%

3.93

-0.03

2.67

3.23

PATM%

2.37

-1.50

2.71

3.19

Notes

Risk Disclosures on Derivatives

Quarterly Results

PANACEA BIOTEC LTD.